SEC Form 4 · accession 0001567619-19-002731

COUNTERPATH CORP · CPAH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP Sales & Marketing

Period of report

Feb 6, 2019

Accepted (ET)

Feb 8, 2019 · 1:23 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001236997

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Shares^F1	Feb 6, 2019	A	118	$1.4799	A	12,353	D
Common Shares^F1	Feb 6, 2019	A	60	$1.462	A	12,413	D
Common Shares	holding	—	—		—	12,235	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options	$19.00	holding	—	—	—	Jul 25, 2013	Jul 25, 2018	Common	5,000	5,000	D
Stock Options	$11.50	holding	—	—	—	Jul 11, 2014	Jul 11, 2019	Common	10,000	15,000	D
Stock Options	$5.00	holding	—	—	—	Jul 17, 2015	Jul 17, 2020	Common	7,500	22,500	D
Stock Options	$2.89	holding	—	—	—	Dec 14, 2017	Dec 14, 2022	Common	50,000	72,500	D
Deferred Share Units^F2	—	holding	—	—	—	Sep 3, 2011	—	Common	2,203	2,203	D
Deferred Share Units^F2	—	holding	—	—	—	Jul 25, 2011	—	Common	1,622	3,824	D
Deferred Share Units^F3	—	holding	—	—	—	Dec 14, 2018	—	Common	40,000	43,824	D

F1These shares were purchased through an Employee Share Purchase Plan.
F2Each deferred share unit is convertible into one common share of CounterPath Corporation at no additional cost. There is no expiry date. The deferred share units are fully vested.
F3Each deferred share unit is convertible into one common share of CounterPath Corporation at no additional cost. There is no expiry date. The deferred share units vest one third over three years beginning on the first anniversary of the grant date.